Patent: 10,280,230
✉ Email this page to a colleague
Summary for Patent: 10,280,230
| Title: | Use of human cells of myeloid leukemia origin for expression of antibodies |
| Abstract: | The invention relates to a method for producing a protein molecule composition having a defined glycosylation pattern, comprising (a) introducing in a host cell which is an immortalized human blood cell at least one nucleic acid encoding at least a part of said protein; and (b) culturing said host cell under conditions which permit the production of said protein molecule composition; and (c) isolating said protein molecule composition. |
| Inventor(s): | Goletz; Steffen (Berlin, DE), Danielczyk; Antje (Berlin, DE), Baumeister; Hans (Berlin, DE), Stahn; Renate (Berlin, DE), Loeffler; Anja (Eichhorst, DE), Stoeckl; Lars (Berlin, DE) |
| Assignee: | Glycotope GmbH (Berlin, DE) |
| Application Number: | 14/703,498 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,280,230
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2026-09-10 |
| Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2026-09-10 |
| Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2026-09-10 |
| Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2026-09-10 |
| Grifols Biologicals Llc | ALBUTEIN | albumin (human) | Injection | 102478 | 08/15/1978 | ⤷ Try a Trial | 2026-09-10 |
| Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 02/17/1995 | ⤷ Try a Trial | 2026-09-10 |
| Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 06/11/2003 | ⤷ Try a Trial | 2026-09-10 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
